Heparin-induced thrombocytopenia type II with early aortocoronary bypass occlusion and stent thrombosis after PTCA of the RCA-treatment with Lepirudin (Refludan®) and Abciximab (Reo pro®) during recanalization of the RCA;Heparin-induzierte thrombozytopenie typ II mit aortokoronarem bypass- fruhverschluss und stentthrombose nach RCA-PTCA-therapie mit Lepirudin (Refludan®) und Abciximab (Reo pro®) im rahmen der rekanalisation

Zeitschrift fur Kardiologie

Volumn 88, Issue 2, 1999, Pages 141-146

  Laubenthal, F C A ^a   Grosch, B ^a   Szurawitzki, G ^a   Sabin, G V ^a  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

Author keywords

Abciximab; HIT type II; Recombinant hirudin; Thromboembolic complications

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FUROSEMIDE; HEPARIN; ISOSORBIDE 5 NITRATE; LEPIRUDIN; METOPROLOL TARTRATE; NIFEDIPINE; PHENPROCOUMON; TICLOPIDINE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; DIAGNOSTIC APPROACH ROUTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART CATHETERIZATION; HEART INFARCTION; HEPARINIZATION; HUMAN; RECANALIZATION; RIGHT CORONARY ARTERY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ARTERY BYPASS; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; STENTS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0033060846     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050270     Document Type: Article

References (18)

1. Coller SB (1997) GPIIb/IIIa-Antagonisten: Pathophysiologie und therapeutische Einblicke aus Studien über cTE3-Fab. Thromb Haemost 78:730-735
2. Brieger DB, Mak K-M, Kootke-Marchant K, Topol EJ (1998) Heparin induced thrombocytopenia. JACC 31:1449-1459
3. Fareed J, Yang L, Hoppenstedt D, Koza M, Walenga JM, Wetzel D (1998) Glykoprotein IIb/IIIa inhibitors can prevent heparin mediated platelet activation in heparin-induced thrombocytopenia. Circulation abstract 1333 (suppl I, 94, No 94)
4. Greinacher A (1995) Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 21:106-116
5. Greinacher A (1996) Heparin-induzierte Thrombozytopenie. Internist 37:1172-1178
6. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C (1994) Heparin-associated thrombocytopenia: Isolation of the antibody and characterisation of a multimolecular PF 4-heparin complex as the major antigen. Thromb Haemost 71:247-251
7. Greinacher A, Völpel H, Pötzsch B (1996) Recombinant hirudin in the treatment of patients with heparin-associated thrombocytopenia. Ann Hematol 72, abstract
8. Hafner G, Rupprecht HJ, Lutz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W (1996) Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris. Eur Heart J 17:1207-1215
9. Kapsch D, Silver D (1981) Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 116:1423-1427
10. Laubenthal F, Sabin GV (1998) Heparin-induzierte Thrombozytopenie-Pathophysiologie, Klinik, Therapie, Prophylaxe. Intensivmed 35:307-315
11. Lefkovits J, Plow EF, Topol EJ (1995) Platelet glykoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 332:1553-1559
12. Muhlestein JB, Karagounis LA, Treehan S, Anderson JL (1997) "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. JACC 30:1729-1734
13. Nurmohamed MT, Berckmans RJ, Morrien-Salomons WM, Berends F, Hommes DW, Rijnierse JJMM, Sturk A (1994) Monitoring anticoagulant therapy by activated partial thromboplastin time: Hirudin assessment. Thromb Haemost 72:685-692
14. Pötzsch B, Madlener K, Seelig C, Riess CF, Greinachcr A, Müller-Berghaus G (1997) Monitoring of r-hirudin during cardiopulmonary bypass - assessment of the whole blood Ecarin clotting time. Thromb Haemost 77:920-925
15. Pondartz G, Pohle K, Stingl D, Bachmann K (1995) Thrombozytenaklivierung und Thrombozytenaggregation am arteriosklerotisch veränderten Endothel. Dtsch Med Wschr 120:1009-1014
16. The EPIC Investigators (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk angioplasty. N Engl Med 330:956-961
17. Visentin GP, Ford SE, Scott JP, Aster RH (1994) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81-88
18. Warkentin ThE, Chong BH, Greinacher A (1998) Heparin-induced thrombocytopenia: Towards consensus. Thromb Haemost 79:1-7